Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, November 10, 2009, 10:49AM ET - U.S. Markets close in 5 hours and 11 minutes. Dow Up 0.12% Nasdaq Down 0.10%
Cephalon Inc. (CEPH)At 10:34AM ET: 59.87  Up 1.13 (1.92%)  
MORE ON CEPH
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Today, Tue, Nov 10, 2009
Bristol Licenses Arthritis Drug: BioBuzz
at TheStreet.com (Tue 9:20am)
ETF Picks: Consider This Diversified Partial Portfolio
at Minyanville.com (Tue 9:10am)
Celgene in the ASH Abstract Spotlight: BioBuzz
at TheStreet.com (Tue 6:31am)
Celgene in ASH Abstract Spotlight: BioBuzz
at TheStreet.com (Tue 6:31am)
Mon, Nov 9, 2009
Bulls Buy Cephalon, WebMD:Options Recap
at TheStreet.com (Mon 4:17pm)
Monday Options Update: GLD, AMR, ANF, CEPH & ESV
at Seeking Alpha (Mon 1:04pm)
Top 10 Stocks for Obamacare
at CNBC (Mon 8:25am)
Sun, Nov 8, 2009
Cephalon's Upside and Downside
at Seeking Alpha (Sun, Nov 8)
Fri, Nov 6, 2009
Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray
Wall Street Transcript (Fri, Nov 6)
Thu, Nov 5, 2009
Alkermes takes 2Q loss, cuts full-year estimates
AP (Thu, Nov 5)
King Beats, but Earnings Down
Zacks.com (Thu, Nov 5)
5-Star Stocks on the Upswing
at Motley Fool (Thu, Nov 5)
Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships
Wall Street Transcript (Thu, Nov 5)
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
PR Newswire (Thu, Nov 5)
Wed, Nov 4, 2009
CEPHALON INC Files SEC form 8-K, Other Events
EDGAR Online (Wed, Nov 4)
Cephalon, Inc. to Webcast R&D Day
PR Newswire (Wed, Nov 4)
Tue, Nov 3, 2009
SPDR Trust, Cephalon: Money Flow Leaders (SPY, CEPH)
at The Wall Street Journal Online (Tue, Nov 3)
Mon, Nov 2, 2009
Award Winning Piper Jaffrey Analyst Sees Transkaryotic Therapeutics Acquisition Paying Off For Shire With Early 2010 Approval Of Velaglucerase
Wall Street Transcript (Mon, Nov 2)
Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder
PR Newswire (Mon, Nov 2)
CEO Interview, Cortex Pharmaceuticals, Inc. - Dr. Mark Varney
Wall Street Transcript (Mon, Nov 2)
Older Headlines - Download Recent Headlines
View headlines from:
Add CEPH News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage